Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Rating of “Moderate Buy” from Analysts
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has […]
27 Jun 06:48 · The Cerbat Gem